Company intelligence / Profile preview

Imuno Brasil

São Paulo, São Paulo, Brazilimunobrasil.com.br ↗

Ownership: Private
Development stage: Commercial

Overview

Imuno Brasil is a healthcare group specializing in the treatment of immune-mediated diseases. It offers advanced medical care and conducts investigator-led clinical studies to improve diagnostic and treatment methods. The company collaborates with international academic institutions for scientific research but does not have its own drug development pipeline or commercialized therapeutics.

Therapeutic areas: GastroenterologyRheumatologyImmunologyNeurology
Industry: Academic Hospital/University/Research

Partnerships

Department of Rheumatology and Immunology at the University Erlangen-Nuremberg (Germany)McCaig Institute for Bone and Joint Health, University of Calgary (Canada)

Beyond the preview

Go deeper on Imuno Brasil.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Imuno Brasil.

Explore the full profile